Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BBI

Brickell Biotech (BBI) Stock Price, News & Analysis

Brickell Biotech logo

About Brickell Biotech Stock (NASDAQ:BBI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.77
$0.93
52-Week Range
N/A
Volume
31,300 shs
Average Volume
206,730 shs
Market Capitalization
$6.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brickell Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBI Stock News Headlines

Brickell hotel sold by royal family member for $55M
Reagan’s former tech advisor sharing bombshell announcement
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
Seattle Biotech News
Nuclear Receptor ROR-Gamma Market Size by 2030
Brickell City Centre
Biotech News
See More Headlines

BBI Stock Analysis - Frequently Asked Questions

Brickell Biotech, Inc. (NASDAQ:BBI) issued its quarterly earnings data on Thursday, August, 11th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($1.48) by $1.47. Brickell Biotech had a negative net margin of 643.48% and a negative trailing twelve-month return on equity of 156.10%.

Brickell Biotech shares reverse split on the morning of Tuesday, July 5th 2022.The 1-45 reverse split was announced on Tuesday, July 5th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 5th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brickell Biotech investors own include Tonix Pharmaceuticals (TNXP), TherapeuticsMD (TXMD), Alphabet (GOOG), NVIDIA (NVDA), Ocugen (OCGN), Meta Platforms (META) and Tesla (TSLA).

Company Calendar

Last Earnings
8/11/2022
Today
9/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BBI
CIK
819050
Employees
16
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($13.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.47 million
Net Margins
-643.48%
Pretax Margin
-643.48%
Return on Equity
-156.10%
Return on Assets
-128.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.36
Quick Ratio
6.36

Sales & Book Value

Annual Sales
$4.64 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.75 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,874,000
Free Float
2,744,000
Market Cap
$6.75 million
Optionable
Not Optionable
Beta
0.02

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:BBI) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners